Anti-obesity Drugs Market Size and Share Anti-obesity Drugs Market Analysis by Mordor Intelligence The Anti-obesity Drugs Market size is projected to be USD 25.93 billion in 2025, USD 34.06 billion in 2026, and reach USD 133.16 billion by 2031, growing at a CAGR of 31.35% from 2026 to 2031
Depending on the preparation method, in combination with the physicochemical characteristics of their structural units, the dimensions of the liposomes range from nanometers to a few micrometers
Common GLP-1 medications include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
Our providers are trained under leading cosmetic surgeons
The mouse lung tissues were stained to identify Eaat3